NL-OMON40394已完成不适用
Pilot study: Dystrophic pathways in human hair follicles after chemotherapy - Path-study
Medisch Centrum Alkmaar0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Female patients with breast cancer
- •- Age 18 years or more
- •- Written informed consent
- •- Indication for at leaust one cycle of intravenous administered Docetaxel-Adriamycin-Cyclofosfamide (TAC), Fluorouracil-Epirubicin-Cyclophosphamide (FEC) or Adriamycin-Cyclophosphamide (AC).
排除标准
- •- Use of scalp cooling
研究者
相似试验
已完成
不适用
Pilot studie: Dystrofische signaalpaden in haarfollikels na chemotherapieSignaalpad, kaalheid, chemotherapie, hoofdhuidkoelingPathway, alopecia, chemotherapy, scalp coolingNL-OMON22244Medisch Centrum Alkmaar10
已完成
不适用
Pilot study: Dystrophyc pathways in human hair follicles after chemotherapy with or without scalp cooling.Hair loss10006288AlopeciaNL-OMON45664oordwest Ziekenhuisgroep20
招募中
不适用
Dystrophic pathways in human hair follicles after chemotherapy with or without scalp coolingChemotherapy, Scalp Cooling, Alopecia, Dystrophic Pathway, Hair follicleChemotherapie, hoofdhuidkoeling, alopecia, dystrofisch signaalpad, haar follikelNL-OMON27897oordwest Ziekenhuisgroep10
已完成
1 期
A study to evaluate the efficacy of test product in hair fall benefitsCTRI/2020/03/023682Diabliss Consumer Products Pvt Ltd36
已完成
不适用
Effect of hair growth KB001JPRN-UMIN000038909Shiba Palace Clinic90